Dr. Linda Chu welcomes Dr. Robert McDonald (Mayo Clinic) and Dr. Paul Evans (GE HealthCare) for a discussion on the evolution of MR contrast agents, exploring how gadolinium has changed MRI diagnostics and what decades of clinical experience have taught the radiology community. The conversation also looks ahead to emerging contrast technologies, including iron and manganese based agents and other innovations that could shape the future of MR imaging, safety, and sustainability.

Sponsored by GE HealthCare

 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The Radiological Society of North America. Innehållet i podden är skapat av The Radiological Society of North America och inte av, eller tillsammans med, Poddtoppen.